Italia markets closed

Abeona Therapeutics Inc. (ABEO)

NasdaqCM - NasdaqCM Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
4,4300-0,2300 (-4,94%)
Alla chiusura: 04:00PM EDT
4,5700 +0,14 (+3,16%)
Dopo ore: 07:35PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente4,6600
Aperto4,6200
Denaro4,3900 x 900
Lettera4,4400 x 2200
Min-Max giorno4,3900 - 4,9900
Intervallo di 52 settimane0,2700 - 34,0000
Volume339.726
Media Volume166.546
Capitalizzazione26,36M
Beta (5 anni mensile)N/D
Rapporto PE (ttm)N/D
EPS (ttm)-0,8080
Prossima data utili11 ago 2022
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1A40,00
  • GlobeNewswire

    Abeona Therapeutics Reports Second Quarter 2022 Financial Results

    Disposition of MPS programs allows Abeona to extend runway of current cash into 2Q 2023 Phase 3 VIITAL™ study topline data expected in late-3Q/early-4Q 2022 upon completion of final patient monitoring visit in mid-September Baseline wound characteristics in VIITAL™ reveal significant scope for pain reduction and EB-101 differentiation NEW YORK and CLEVELAND, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in cell and gene therapy, today announ

  • GlobeNewswire

    Abeona Therapeutics Regains Compliance with Nasdaq Listing Requirements

    NEW YORK and CLEVELAND, July 20, 2022 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that it received notice from The Nasdaq Stock Market LLC (Nasdaq) on July 19, 2022 informing Abeona that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the “Rule”) for continued listing on The Nasdaq Capital Market. In order to regain compliance with the Rule, the Company’s common stock was required to maintain a minimum closin

  • GlobeNewswire

    Abeona Therapeutics to Present at the Jefferies Healthcare Conference

    NEW YORK and CLEVELAND, June 06, 2022 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in cell and gene therapy, today announced that company management is scheduled to present at the Jefferies Healthcare Conference on Thursday, June 9, 2022, at 3:30 p.m. EDT. A live webcast of the presentation will be available on the Investors section of the Abeona website under "Events" at https://investors.abeonatherapeutics.com/events. The webcast will be archived for 3